Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2007
03/15/2007WO2007028231A1 Method and apparatus for measuring analytes
03/15/2007WO2007028212A1 Noggin and chimeric molecules thereof
03/15/2007WO2007014001A9 Multiplex determination of lipid specific binding moieties
03/15/2007WO2007010145A3 Saccharide fluorescent substrates, preparation method and uses thereof
03/15/2007WO2007008758A3 Methods for identifying agents and conditions that modulate neurogenesis
03/15/2007WO2007003398A3 Electrode assembly, use thereof, and method for the production thereof
03/15/2007WO2007002037A9 Trace sampling
03/15/2007WO2006133325A3 Analysis of tissue samples surrounding malignancies
03/15/2007WO2006133164A3 Anti-trkb monoclonal antibodies and uses thereof
03/15/2007WO2006131853A3 In vivo expression profiling
03/15/2007WO2006130299A3 Microfluidic laminar flow detection strip
03/15/2007WO2006124644A3 Protein and antibody profiling using small molecule microarrays
03/15/2007WO2006121912A3 Diagnostic methods for the detection of risk of neurodevelopmental disorders
03/15/2007WO2006121422A3 Antibodies against clostridium difficile toxins and uses thereof
03/15/2007WO2006119368A3 Fluorescent detection system and dye set for use therewith
03/15/2007WO2006119013A3 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same
03/15/2007WO2006116327A9 Uses of parylene membrane filters
03/15/2007WO2006116325A3 Multiple-valent opsonophagocytic assay selection panel arrays and uses therefor
03/15/2007WO2006110449A3 Agglomeration protein cascades, compositions and methods regarding the same
03/15/2007WO2006108033A3 Recombinant antigens for the detection of coxiella burnetii
03/15/2007WO2006102128A3 System, method and computer program for non-binary sequence comparison
03/15/2007WO2006099451A3 Novel human, feline, chicken and other animal interferons and uses thereof
03/15/2007WO2006088951A3 Cd38 modulated chemotaxis
03/15/2007WO2006083992A3 Egg testing apparatus and method
03/15/2007WO2006078994A3 Continuous flow chamber device for separation, concentration, and/or purification of cells
03/15/2007WO2006068481A3 Novel necrosis and ethylene inducing proteins from botrytis
03/15/2007WO2006065763A3 Medication treatment selection stategy and clinical model methods
03/15/2007WO2006052534A3 Expansion of nk cells and therapeutic uses thereof
03/15/2007WO2006026785A3 COMPOSITIONS AND METHODS FOR MODULATING PGC-1α TO TREAT NEUROLOGICAL DISEASES AND DISORDERS
03/15/2007WO2006024788A8 Method and device for measuring an enzymatic activity in a body fluid
03/15/2007WO2006017175A3 Combination assay for alcohol and drugs of abuse
03/15/2007WO2006007494A3 Bumper impact-testing device
03/15/2007WO2006003029A3 Detection of tuberculosis and infection by mycobacterium tuberculosis using hbha
03/15/2007WO2005123993A8 Phage microarray profiling of the humoral response to disease
03/15/2007WO2005119259A3 Population based prediction methods for immune response determinations and methods for verifying immunological response data
03/15/2007WO2005069872A3 High throughput pharmaceutical screening using drosophila
03/15/2007WO2005063745A8 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
03/15/2007WO2005023202A3 Tumor suppressor lkb1 kinase directly activates amp-activated kinase
03/15/2007WO2004111201A3 Data classification using point-wise tests
03/15/2007WO2004031733A3 Methods of generating and screenign for porteases with altered specificity
03/15/2007WO2003093432A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/15/2007WO2003082006A3 Methods and compositions for preventing obesity and obesity related disorders
03/15/2007WO2003074659A3 Magnetic immobilization of cells
03/15/2007US20070061906 Human T2R75 taste receptor and related assays for identifying human bitter taste modulators
03/15/2007US20070061905 screening mammalian chemosensory G Protein-Coupled Receptors active in taste signaling; genes and cDNA encoding such receptors
03/15/2007US20070061904 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators
03/15/2007US20070061903 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste
03/15/2007US20070061902 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste
03/15/2007US20070061167 Remote health monitoring and maintenance system
03/15/2007US20070061086 Cardiotoxin molecular toxicology modeling
03/15/2007US20070060645 Purification of cinacalcet
03/15/2007US20070060548 Modulation of Epac, phospholipase Cepsilon, and phospholipase D to treat pain
03/15/2007US20070060539 Shc proteins as therapeutic targets in proliferative diseases
03/15/2007US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy
03/15/2007US20070060515 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
03/15/2007US20070059845 Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
03/15/2007US20070059843 Method of high-speed detection for biological analyte
03/15/2007US20070059842 identifying proteins or peptides at greater speed and with improved accuracy; reducing processing time
03/15/2007US20070059841 Providing a solution of an acridan compound and a peroxide, electrochemically oxidizing the acridan compound at a electrode to form an oxidized intermediate compound wherein the oxidized intermediate compound reacts with the peroxide provided in the solution to produce the chemiluminescence
03/15/2007US20070059840 Hemostasis Analysis Device and Method
03/15/2007US20070059837 Method for noticing changes in a package, method for locating a package, package and system for locating a package
03/15/2007US20070059821 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents
03/15/2007US20070059806 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
03/15/2007US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell
03/15/2007US20070059794 Chaperonin-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release formulation, and method of producing antibody against target protein
03/15/2007US20070059787 Kinase and phosphatase assays
03/15/2007US20070059786 Chemiluminescence enhancer
03/15/2007US20070059785 Biomarkers in cancer
03/15/2007US20070059784 Methods for measuring the insulin receptor alpha subunit
03/15/2007US20070059783 Method of identifying markers diagnostic of disease and uses therefor in the diagnosis of cancer
03/15/2007US20070059782 Magnetic particle tagged blood bank reagents and techniques
03/15/2007US20070059781 System for size based separation and analysis
03/15/2007US20070059780 Incorporation of highly specific receptors into an amplification mechanism, including antibody-embedded liquid crystalline materials, for the rapid and automatic detection of ligands, particularly pathogens and/or their toxins; can be used for early diagnoses
03/15/2007US20070059779 Biocatalytic solgel microarrays
03/15/2007US20070059778 Modified colony assay
03/15/2007US20070059777 Thrombin-induced fibrinogen binding for the detection of risk of bleeding disorders
03/15/2007US20070059776 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
03/15/2007US20070059775 Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and MR imaging techniques
03/15/2007US20070059774 Kits for Prenatal Testing
03/15/2007US20070059773 Identification of therapeutic compounds
03/15/2007US20070059772 Phosphorylated glyoxalase I and its use
03/15/2007US20070059771 Protein O-sulfonation
03/15/2007US20070059770 Reference Database
03/15/2007US20070059769 High throughput glycan microarrays
03/15/2007US20070059767 Method of identifying N-terminal proBNP
03/15/2007US20070059765 Liposome-based microarray and methods of use thereof
03/15/2007US20070059764 Electrospray coating of aerosols for labeling and identification
03/15/2007US20070059763 Cellomics system
03/15/2007US20070059762 Insulin resistance curative and method of screening the same
03/15/2007US20070059761 Storage and use of colloids
03/15/2007US20070059759 Human T2R63 receptor and related assays for identifying human bitter taste modulators
03/15/2007US20070059757 Method and compositions for the treating diseases targeting E-cadherin
03/15/2007US20070059737 Gene expression profiling in biopsied tumor tissues
03/15/2007US20070059734 Reagent for detecting biopolymer and method for detecting biopolymer
03/15/2007US20070059733 Method for sequencing nucleic acids by observing the uptake of nucleotides modified with bulky groups
03/15/2007US20070059729 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
03/15/2007US20070059726 Differential transcript expression
03/15/2007US20070059724 Novel compositions and methods for lymphoma and leukemia
03/15/2007US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
03/15/2007US20070059722 Novel genes and markers associated to type 2 diabetes mellitus
1 ... 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 ... 3937